Quick answers
- What is Amitza?
- Amitza is a brand name of Lubiprostone, a prescription medicine. The FDA NDC Directory lists 1 Amitza product in 1 strength and form.
- Who makes Amitza?
- Teva Pharms USA Inc holds the FDA application for Amitza (ANDA209920, approved January 18, 2022).
- Is there a generic or store brand of Amitza?
- Yes. The FDA NDC Directory lists 13 other products with the same active ingredients, strength and form as a Amitza product, 11 of them generic. Ask your pharmacist whether one is right for you.
- Has Amitza been recalled?
- No recall linked to Amitza products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Amitza is
Each Amitza product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Lubiprostone · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| lubiprostone 8 ug capsule, gelatin coated (oral) | Amitza | 13 products, 12 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Lubiprostone →
FDA approval
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| ANDA209920 | Teva Pharms USA Inc | January 18, 2022 | 1 |
Companies that list Amitza
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Amitza products.
- Direct_Rx1 product
Recalls
No recall linked to Amitza products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.